BNO
Click for more information
5.26% 20.0¢ bionomics limited

Ann: BNC105 Clinical Trial In Combination With Nivolumab, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. windshift
    593 Posts.
    lightbulb Created with Sketch. 24
    clock Created with Sketch.
    11/01/19
    10:54
    Post #: 37089766

    I don't want to speculate about the possibility of BNC105 as a combo producing a positive trial outcome. But, I reiterate that it is worth a shot as a combo treatment. Plenty of success stories with combo treatments. However, I also have to agree that it is secondary to the the forthcoming outcome of the "agitation" trial. There is quite a bit riding on that trial. GLTA


    BNO Price at posting: 12.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Experienced CEO appointed to Indiana Resources
right-arrow Created with Sketch.
MKG Encouraging results for Raiden as Pegmatite extensions confirmed
right-arrow Created with Sketch.
NEWS Share Purchase Plan by robotic technology company now complete
right-arrow Created with Sketch.
NEWS MTM and Indium form strategic collaboration for recovering Gallium and Germanium
right-arrow Created with Sketch.
NEWS Significant milestone reached in Zimbabwe's oil and gas exploration industry as Invictus Energy moves closer to execution
right-arrow Created with Sketch.
NEWS High grade drill results discovered at CODA North
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.